Yuhan Yang

The paper identifies a WIF1+ basal cell subtype enriched in the transition zone of the prostate and links it to benign prostatic hyperplasia through molecular and pathway analyses.

This paper identifies triptolide as a compound that enhances the effectiveness of DNMTi by inhibiting DCTPP1, overcoming resistance in cancer cells.

This study shows CRM1 regulates androgen receptor stability and DNA repair in prostate cancer, suggesting combination therapy with CRM1 and DNA repair inhibitors could be effective.